PMC:7228307 / 11455-11601 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"216","span":{"begin":20,"end":24},"obj":"Gene"},{"id":"224","span":{"begin":82,"end":88},"obj":"Species"},{"id":"226","span":{"begin":0,"end":7},"obj":"Gene"}],"attributes":[{"id":"A216","pred":"tao:has_database_id","subj":"216","obj":"Gene:3502"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Tax:9606"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"Gene:2212"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T99","span":{"begin":95,"end":105},"obj":"Body_part"},{"id":"T100","span":{"begin":110,"end":119},"obj":"Body_part"},{"id":"T101","span":{"begin":133,"end":146},"obj":"Body_part"}],"attributes":[{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma62869"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T199","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T200","span":{"begin":58,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T201","span":{"begin":133,"end":134},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T73","span":{"begin":95,"end":105},"obj":"http://purl.obolibrary.org/obo/CL_0000738"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"216","span":{"begin":20,"end":24},"obj":"Gene"},{"id":"224","span":{"begin":82,"end":88},"obj":"Species"},{"id":"226","span":{"begin":0,"end":7},"obj":"Gene"}],"attributes":[{"id":"A224","pred":"pubann:denotes","subj":"224","obj":"Tax:9606"},{"id":"A226","pred":"pubann:denotes","subj":"226","obj":"Gene:2212"},{"id":"A216","pred":"pubann:denotes","subj":"216","obj":"Gene:3502"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T63","span":{"begin":0,"end":146},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T98","span":{"begin":95,"end":105},"obj":"Body_part"},{"id":"T99","span":{"begin":110,"end":119},"obj":"Body_part"},{"id":"T100","span":{"begin":133,"end":146},"obj":"Body_part"}],"attributes":[{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma62869"},{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":0,"end":146},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}

{"project":"LitCovid-sample-Glycan","denotations":[{"id":"T1","span":{"begin":91,"end":94},"obj":"https://glytoucan.org/Structures/Glycans/G05518TD"}],"text":"FcγRIIa Low IgG1, IgG3, but IgG2 binding limited to the FcγRIIa‐H131 form, ~70% people) All leukocytes and platelets except T and B lymphocytes"}